Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

331.21 -7.49 (-2.21%)

Streaming Delayed Price Updated: 11:02 AM EDT, Aug 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

3 Healthcare Stocks with Promising Prospects

August 27, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Via StockStory

Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal ↗

August 26, 2026

Duquesne Family Office has beefed up its healthcare holdings.

Via The Motley Fool

Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either. ↗

August 24, 2026

Natera's growth, expanding role in cancer care, and growing diagnostic data platform help explain why Druckenmiller has made it a major portfolio holding, despite valuation and regulatory risks.

Via The Motley Fool

Natera (NASDAQ:NTRA) Beats Q2 Estimates, Raises Full-Year Revenue Guidance ↗

August 06, 2026

Via Chartmill

3 Large-Cap Stocks Worth Investigating

August 24, 2026

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...

Via StockStory

2 Biotech Stocks Shaping Up for Major Breakouts ↗

August 22, 2026

Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts.

Via MarketBeat

Topics ETFs

Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? ↗

August 20, 2026

The hedge fund legend has bet much of the family office on this one diagnostics company.

Via The Motley Fool

Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today ↗

August 18, 2026

Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 27.63% on an annualized basis producing an average annual return of 40.99%. Currently, Natera has a market capitalization of...

Via Benzinga

Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks

August 17, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f...

Via StockStory

Topics Artificial Intelligence

Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference ↗

August 15, 2026

Natera (NASDAQ:NTRA) Chief Financial Officer Mike Brophy said the company delivered strong second-quarter momentum across its women’s health, oncology and organ health businesses, citing record...

Via MarketBeat

Natera (NTRA) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Oncology volumes jumped 57.2% on MRD adoption gains.

Via The Motley Fool

Topics Earnings

5 Insightful Analyst Questions From Natera’s Q2 Earnings Call

August 13, 2026

Natera’s second quarter results were positively received by the market, driven by robust sales volume growth and ongoing momentum in both established and eme...

Via StockStory

Topics Earnings

What to Know About This Natera Insider Transaction as Shares Surge to Record Highs ↗

August 10, 2026

Moshkevich's non-discretionary sale was executed to cover tax withholding on vesting RSUs under a Rule 10b5-1 plan.

Via The Motley Fool

Topics Regulatory Compliance

A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests ↗

August 10, 2026

This sale was executed under a pre-arranged Rule 10b5-1 trading plan.

Via The Motley Fool

Topics Regulatory Compliance

Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know ↗

August 10, 2026

This sale was non-discretionary and executed under a Rule 10b5-1 plan to cover tax withholding from RSU vesting.

Via The Motley Fool

Topics Regulatory Compliance

A Natera Insider's Shares Vested Before the Firm Reported Revenue Surged 38%. Here's How to Read It ↗

August 10, 2026

This was a non-discretionary sale to cover tax withholding on vesting equity awards under a Rule 10b5-1 plan.

Via The Motley Fool

Topics Regulatory Compliance

A Natera Co-Founder Sold Into Record Highs. Here's What Long-Term Investors Should Know ↗

August 10, 2026

Sheena executed 9,150 shares under a pre-established trading plan adopted in December 2025.

Via The Motley Fool

Topics Regulatory Compliance

Stanley Druckenmiller's Portfolio Skips Megacap Tech Almost Entirely. Here's What He's Buying Instead. ↗

August 08, 2026

Druckenmiller only owns one "Magnificent Seven" stock.

Via The Motley Fool

Topics Artificial Intelligence

NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth

August 07, 2026

Genetic testing company Natera (NASDAQ:NTRA) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 37.7% year on year to $752.8...

Via StockStory

Natera Q2 Earnings Call Highlights ↗

August 07, 2026

Natera (NASDAQ:NTRA) reported second-quarter 2026 revenue of approximately $753 million, up about 38% from a year earlier, as record testing volumes and higher average selling prices supported growth...

Via MarketBeat

Topics Earnings

3 Growth Stocks with All-Star Potential

August 07, 2026

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...

Via StockStory

Topics Energy

Natera (NASDAQ:NTRA) Reports Strong Q2 CY2026, Stock Jumps 16.3%

August 06, 2026

Genetic testing company Natera (NASDAQ:NTRA) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 37.7% year on year to $752.8 mi...

Via StockStory

Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗

August 05, 2026

Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 24.85% on an annualized basis producing an average annual return of 38.28%. Currently, Natera has a market capitalization of...

Via Benzinga

Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 04, 2026

Genetic testing company Natera (NASDAQ:NTRA) will be announcing earnings results this Thursday afternoon. Here’s what investors should know. Natera beat anal...

Via StockStory

Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy? ↗

August 04, 2026

The company has made massive strides in medical diagnostics and is growing at a rapid clip.

Via The Motley Fool

Topics Intellectual Property

July 27, 2026

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Via StockStory

3 Reasons We’re Fans of Natera (NTRA)

July 24, 2026

Natera has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.1% to $263.44 per...

Via StockStory

Topics Stocks

3 Market-Beating Stocks Worth Your Attention

July 22, 2026

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that ca...

Via StockStory

Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves. ↗

July 16, 2026

It may not be a familiar name, but Natera has provided better returns than Nvidia over the past 12 months.

Via The Motley Fool

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

July 15, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Natera (NASDAQ:NTRA) and its ...

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.